The influence of intrapartum opioid use on breastfeeding experience at 6 weeks post partum: A secondary analysis

To examine breastfeeding experiences up to 6 weeks postpartum for mothers administered intranasal fentanyl, subcutaneous fentanyl or intramuscular pethidine for intrapartum analgesia. A secondary analysis was undertaken using the per-protocol dataset to examine the third phase of a larger randomised...

Full description

Saved in:
Bibliographic Details
Published in:Midwifery 2017-07, Vol.50, p.106-109
Main Authors: Fleet, Julie-Anne, Jones, Meril, Belan, Ingrid
Format: Article
Language:English
Subjects:
Adult
Analgesia
Analgesics, Opioid - adverse effects
Breast Feeding - psychology
Breastfeeding
Breastfeeding & lactation
Childbirth & labor
Clinical trials
Female
Fentanyl
Fentanyl - administration & dosage
Fentanyl - therapeutic use
Humans
Intrapartum
Labor Pain
Life Change Events
Maternal characteristics
Maternal child nursing
Maternity hospitals
Medical records
Mothers
Narcotics
Nasal sprays
Newborn babies
Nursing
Opioids
Pain
Pain Management - adverse effects
Pain Management - methods
Perinatal Care - methods
Perinatal Care - standards
Pethidine
Postpartum period
Postpartum Period - drug effects
Postpartum Period - psychology
Postpartum women
Pregnancy
South Australia
Surveys and Questionnaires
Telephone surveys
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To examine breastfeeding experiences up to 6 weeks postpartum for mothers administered intranasal fentanyl, subcutaneous fentanyl or intramuscular pethidine for intrapartum analgesia. A secondary analysis was undertaken using the per-protocol dataset to examine the third phase of a larger randomised controlled trial. This phase of the study examined breastfeeding intention and experience from the first hour of birth to 6 weeks postpartum. Medical records were audited and women were contacted at 6 weeks postpartum to complete a telephone questionnaire. Two maternity hospitals in South Australia. Healthy women birthing at term received intranasal fentanyl (n=37), subcutaneous fentanyl (n=37), or intramuscular pethidine (n=35). While maternal characteristics and birth outcomes were comparable between groups, women who received either intranasal fentanyl or subcutaneous fentanyl experienced fewer difficulties in establishing breastfeeding by 6 weeks postpartum when compared to intramuscular pethidine (p
ISSN:0266-6138
1532-3099
DOI:10.1016/j.midw.2017.03.024